Lisha Zhou

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum

Top Venues

Cell death discovery

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Xiongzhi Lin, Dongsheng Sun, Shuhan Yang, Kai Cheng, XingYi Wang, Weijia Meng, Haowei Wu, Wenlin Liu, Xiaoyu Wu, Hui Yang, Xiaojun Wang, Lisha Zhou
UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. Cell death & disease 15 (8) (2024)
Xiongzhi Lin, Dongsheng Sun, Shuhan Yang, Kai Cheng, XingYi Wang, Weijia Meng, Haowei Wu, Wenlin Liu, Xiaoyu Wu, Hui Yang, Xiaojun Wang, Lisha Zhou
UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. Cell death & disease 15 (8) (2024)
Xiongzhi Lin, Dongsheng Sun, Shuhan Yang, Kai Cheng, XingYi Wang, Weijia Meng, Haowei Wu, Wenlin Liu, Xiaoyu Wu, Hui Yang, Xiaojun Wang, Lisha Zhou
UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. Cell death & disease 15 (8) (2024)
Lisha Zhou, Xiongzhi Lin, Jin Zhu, Luyi Zhang, Siyuan Chen, Hui Yang, Lijun Jia, Baofu Chen
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. Cell death discovery 9 (1) (2023)
Lisha Zhou, Xiongzhi Lin, Jin Zhu, Luyi Zhang, Siyuan Chen, Hui Yang, Lijun Jia, Baofu Chen
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. Cell death discovery 9 (1) (2023)
Lisha Zhou, Xiongzhi Lin, Jin Zhu, Luyi Zhang, Siyuan Chen, Hui Yang, Lijun Jia, Baofu Chen
NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. Cell death discovery 9 (1) (2023)